Wolverine Trading’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-12,800
Closed -$579K 5482
2021
Q4
$579K Buy
12,800
+7,900
+161% +$412K ﹤0.01% 3261
2021
Q3
$297K Buy
+4,900
New +$373K ﹤0.01% 4719
2021
Q2
Sell
-8,500
Closed -$535K 6074
2021
Q1
$535K Buy
8,500
+4,600
+118% +$357K ﹤0.01% 3601
2020
Q4
$292K Buy
+3,900
New +$226K ﹤0.01% 3770
2020
Q1
Sell
-20,600
Closed -$432K 4676
2019
Q4
$432K Sell
20,600
-6,000
-23% -$138K ﹤0.01% 3205
2019
Q3
$581K Buy
26,600
+19,400
+269% +$537K ﹤0.01% 2474
2019
Q2
$259K Buy
+7,200
New +$230K ﹤0.01% 3426
2019
Q1
Sell
-15,400
Closed -$362K 4575
2018
Q4
$362K Sell
15,400
-30,200
-66% -$776K ﹤0.01% 2983
2018
Q3
$1.32M Buy
+45,600
New +$853K ﹤0.01% 2055

Other funds holding CDNA

Wolverine Trading's CDNA Position: Q1 2022 in Review

Wolverine Trading sold out of CareDx (CDNA) in Q1 2022, closing a stake of 8,176 shares — an estimated $370K sold.

Wolverine Trading first reported a position in CDNA in Q3 2018 and held it in 8 quarters. The position peaked at $850K in Q3 2018. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.

  • Wolverine Trading reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
  • Wolverine Trading sold 8,176 CareDx shares in Q1 2022, an estimated $370K.
  • Wolverine Trading first reported a position in CareDx in Q3 2018 and held it in 8 quarters.
  • Wolverine Trading's CareDx position peaked at $850K in Q3 2018.
  • 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.

Based on Wolverine Trading's 13F filing for Q1 2022, filed 16 May 2022.